| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.60B | — | +23.3% |
| Cost of Revenue | $605.0M | — | +26.6% |
| R&D Expense | $303.0M | — | +21.7% |
| SG&A Expense | $447.0M | — | +23.8% |
| Operating Income | $248.0M | — | +13.8% |
| Pre-tax Income | $198.0M | — | -0.5% |
| Income Tax | -$83.0M | — | -376.7% |
| Net Income | $281.0M | — | +66.3% |
| EPS (Basic) | $1.64 | — | +69.1% |
| EPS (Diluted) | $1.63 | — | +68.0% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.18B | +16.3% | +5.7% |
| Accounts Receivable | $914.0M | -2.7% | +14.7% |
| Inventory | $1.05B | -0.2% | +0.9% |
| Current Assets | $4.70B | +8.1% | +5.5% |
| Total Assets | $11.48B | +1.6% | +22.3% |
| Current Liabilities | $1.80B | -2.4% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $441.0M | — | +16.7% |
| Capital Expenditures | $34.0M | — | +6.3% |
| Investing Cash Flow | -$44.0M | — | -33.3% |
| Financing Cash Flow | -$99.0M | — | -33.8% |
| Free Cash Flow | $407.0M | — | +17.6% |
| +19.6% |
| Long-term Debt | $2.53B | +0.0% | +41.6% |
| Total Liabilities | $5.28B | -2.7% | +25.6% |
| Stockholders' Equity | $6.21B | +5.5% | +19.6% |